In this study, the new 4-iodo-N- (6-sulfamoylbenzothiazol-2-yl) benzamide (L3) obtained from 2-amino-6-sulfamoylbenzothiazole (L1) and 4-iodobenzoyl chloride (L2) and Fe (II) Fe (L3) 2 (SO4). H2O (1), Ni (II) Ni (L3) 2 (Ac) 2. 2H2O (2) and Cu (II) Cu (L3) 2 (Ac) 2. 2H2O (3) complexes were synthesized. The structures were synthesized by elemental analysis for L3 and 1-3, infrared spectroscopy (IR) for L3 and 1-3, nuclear magnetic resonance (NMR) for L3, atomic absorption spectroscopy (AAS), molar conductivity, and magnetic susceptibility methods for 1-3. As a consequence of spectroscopic evaluation, it was determined that compounds 1-3 exhibited a non-ionic and tetrahedral conformation. A comprehensive examination was conducted on the susceptibility of all substances to C. albicans (yeast), L. monocytogenes, E. faecalis, E. coli, P. aeruginosa, S. aureus, and B. subtilis (bacteria) were thoroughly investigated. The antimicrobial activities were contrasted with those of Ketoconazole, Fluconazole, Levofloxacin, Chloramphenicol, Vancomycin, and Cefepime.
İlki̇men et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: